Continuous glucose monitoring in women with early onset type 2 diabetes in pregnancy
In plain English
AI plain-English summaryPregnant women with early-onset type 2 diabetes face a 20-fold higher risk of losing their baby, yet no one knows what blood sugar targets their continuous glucose monitors should aim for. This matters because early-onset type 2 diabetes—diagnosed before age 40—is rising sharply in pregnancy, especially among women from ethnic minority or deprived backgrounds who are typically excluded from research. Continuous glucose monitors have transformed pregnancy outcomes for type 1 diabetes, where keeping blood sugar in range more than 70% of the time is linked to healthier births. But for early-onset type 2 diabetes, those targets simply do not exist. The research will combine a systematic review, a new observational study tracking glucose and lifestyle data, and interviews with women from diverse backgrounds to identify what glucose levels actually predict safe pregnancies in this group. If successful, the findings could give clinicians concrete, evidence-based glucose targets for managing early-onset type 2 diabetes in pregnancy. That would make antenatal care safer and more equitable for a growing population of mothers and babies currently navigating pregnancy without a clear benchmark.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
StudentshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know